Telix Pharmaceuticals | TLX - Sales Revenues

Stock Price
14.24
Daily Change
0.64 4.71%
Monthly
-15.69%
Yearly
-21.54%
Q3 Forecast
13.73

Telix Pharmaceuticals reported AUD309.72M in Sales Revenues for its fiscal semester ending in June of 2025.



Financials
Stock Price AUD
Assets AUD 1.52B
Cash and Equivalent AUD 710.35M
Cost of Sales AUD 148.66M
Current Assets AUD 918.56M
Current Liabilities AUD 330.91M
Debt AUD 581.45M
EBIT AUD 37.44M
EBITDA AUD 33.24M
EPS Earnings Per Share AUD 0.28
Equity Capital and Reserves AUD 568.21M
Gross Profit on Sales AUD 129.12M
Interest Expense on Debt AUD 3.39M
Interest Income AUD 1.37M
Loan Capital AUD 551.82M
Market Capitalization AUD 4.41B
Net Income AUD 10.13M
Operating Expenses AUD 191.9M
Operating Profit AUD 17.72M
Ordinary Share Capital AUD 334.73M
PE Price to Earnings AUD 164.4
Pre-Tax Profit AUD 10.69M
Sales Revenues AUD 309.72M
Selling and Administration Expenses AUD 55.91M
Stock AUD 38.14M
Trade Creditors AUD 68.7M
Trade Debtors AUD 158.99M

Sales Change Date
Cochlear AUD 1.17B 34.7M Dec/2024
CSL USD 8.21B 1.47B Dec/2024
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 195.04M 5.43M Jun/2025
Medical Developments International AUD 7.54M 0 Dec/2023
Mesoblast USD 1.56M 950K Dec/2024
Neuren Pharmaceuticals AUD 194.1M 163.93M Dec/2024
Pacific Edge NZD 10.96M 5.32M Sep/2024
Paradigm Biopharmaceuticals AUD 433.66K 4.81M Dec/2024
Polynovo AUD 34.58M 24.94M Jun/2025
PYC Therapeutics AUD 12.69M 6.11M Dec/2024
Ramsay Health Care AUD 9.29B 700M Dec/2025
ResMed USD 1.35B 65.9M Jun/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025